Literature DB >> 8718433

Prevalence of self-reported erectile dysfunction in people with long-term IDDM.

R Klein1, B E Klein, K E Lee, S E Moss, K J Cruickshanks.   

Abstract

OBJECTIVE: The purpose of this report is to examine the prevalence of erectile dysfunction and relationships to other characteristics in men with younger-onset diabetes. RESEARCH DESIGN AND METHODS: In a population-based cohort study in southern Wisconsin, prevalence of erectile dysfunction was measured based on self reports in men who were 21 years of age or older, were < 30 years of age at diagnosis of diabetes, had 10 or more years of diabetes, and were taking insulin (n = 365).
RESULTS: Of the study group, 20% reported a history of erectile dysfunction. The prevalence of erectile dysfunction increased with increasing age (from 1.1% in those 21-30 years of age to 47.1% in those 43 years of age or older, P for trend < 0.0001) and with increasing duration of diabetes (P for trend < 0.0001). Erectile dysfunction was associated with presence of severe diabetic retinopathy, a history of peripheral neuropathy, amputation, cardiovascular disease, a higher glycosylated hemoglobin, use of antihypertensive medications, and higher BMI.
CONCLUSIONS: These data suggest that tighter glycemic control and careful selection of antihypertensive medications might prove beneficial.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8718433     DOI: 10.2337/diacare.19.2.135

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

Review 1.  Erectile dysfunction and atherosclerosis.

Authors:  Robert A Kloner; Mark Speakman
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

2.  Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.

Authors:  Neha Singh; Goutham Vasam; Rahul Pawar; Yagna P R Jarajapu
Journal:  J Sex Med       Date:  2014-06-23       Impact factor: 3.802

3.  Men with diabetes may require more aggressive treatment for erectile dysfunction.

Authors:  T J Walsh; J M Hotaling; A Smith; C Saigal; H Wessells
Journal:  Int J Impot Res       Date:  2013-12-19       Impact factor: 2.896

Review 4.  Erectile dysfunction: interrelationship with the metabolic syndrome.

Authors:  Glenn Matfin; Ali Jawa; Vivian A Fonseca
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

5.  Four-year review of sildenafil citrate.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2002

6.  Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men.

Authors:  Arie Roth; Ofra Kalter-Leibovici; Yehuda Kerbis; Ella Tenenbaum-Koren; Juza Chen; Tamar Sobol; Itamar Raz
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 7.  Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient.

Authors:  Robert A Kloner
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 8.  Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor?

Authors:  Nikolaos Zias; Vishnu Bezwada; Sean Gilman; Alexandra Chroneou
Journal:  Sleep Breath       Date:  2008-09-03       Impact factor: 2.816

9.  Survey on the perception of urogenital complications in diabetic patients.

Authors:  Jong Wook Kim; Ji Yun Chae; Jin Wook Kim; Cheol Yong Yoon; Mi Mi Oh; Je Jong Kim; Du Geon Moon
Journal:  World J Mens Health       Date:  2012-12-27       Impact factor: 5.400

Review 10.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.